SARS-CoV-2 Assay
The SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider.
Availability: Commercially Available
Dr. Amy L. Leber
Director, Clinical Microbiology and Immunoserology, Department of Laboratory Medicine
+1 614 722 2000
700 Children’s Drive, Bldg H, Rm H-LL D00620
Columbus, OH 43205
USA
|
|
www.nationwidechildrens.org
| Manufacturer |
| Nationwide Children's Hospital |
| Product Name |
| SARS-CoV-2 Assay |
| Detection Category |
| Biological |
| Detection Principle |
| Molecular; |
| Detection Method |
| Assays;Nucleic Acid Amplification; |
| Application |
| Diagnostics; |
| Equipment Type |
| Diagnostic |
| Product Synopsis |
| The SARS-CoV-2 Assay is a real-time RT-PCR assay intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasal, midturbinate, nasopharyngeal, and oropharyngeal swab specimens) from individuals suspected of COVID-19 by their healthcare provider. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| April 2020 |
| User Feedback Sources |
| Indifferent/No user feedback |
| No Information Is Available |
| Transportability |
| Pocket Size |
| Other Biological Targets |
| SARS-CoV-2 |
| Training Required |
| <1 day training |